Abstract

The cover picture shows the structure (in red, right) of the lipophilic polyketide toxin mycolactone obtained from the reference Ghana strain of Mycobacterium ulcerans, the causative agent of the emerging disease Buruli ulcer, and that (in red, left) of a molecular variant of mycolactone newly identified from a clinical isolate of M. ulcerans from China. The new variant bears a single additional methyl group in the sidechain, as shown by mass spectrometry. Also shown at the top is the difference detected between the structural genes; this difference is dictated by a precise acyltransferase (AT) domain swap in the chain‐building polyketide synthase, so that a propionate (Pr) unit is recruited rather than an acetate (Ac) unit. Detailed information about this apparent natural example of polyketide biosynthetic engineering is reported by P. Leadley et al. on p. 643 ff.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.